270 results
8-K
EX-10.1
JAGX
Jaguar Health Inc
1 Mar 24
Entry into a Material Definitive Agreement
5:30pm
8-K
EX-10.2
JAGX
Jaguar Health Inc
1 Mar 24
Entry into a Material Definitive Agreement
5:30pm
8-K
EX-10.1
JAGX
Jaguar Health Inc
1 Dec 23
Entry into a Material Definitive Agreement
5:25pm
8-K
EX-10.2
JAGX
Jaguar Health Inc
1 Dec 23
Entry into a Material Definitive Agreement
5:25pm
8-K
EX-10.1
JAGX
Jaguar Health Inc
5 Oct 23
Entry into a Material Definitive Agreement
5:03pm
8-K
EX-10.2
ru3xvhvac1y gv9yoff3
3 Jul 23
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-10.1
vm391
3 Jul 23
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-10.1
hnl4o
19 May 23
Departure of Directors or Certain Officers
5:00pm
8-K
EX-10.2
yve8uofbv17m
9 May 23
Jaguar Completes Enrollment in its Pivotal Phase 3 OnTarget Trial of Crofelemer for Prophylaxis of Cancer Therapy-Related Diarrhea
8:30am
8-K
EX-10.1
ogoa7a0m ar2q9zx
9 May 23
Jaguar Completes Enrollment in its Pivotal Phase 3 OnTarget Trial of Crofelemer for Prophylaxis of Cancer Therapy-Related Diarrhea
8:30am
8-K
EX-10.1
lfaw1b2ax jtez42
6 Feb 23
Entry into a Material Definitive Agreement
5:01pm
8-K
EX-10.1
jsmi6
30 Dec 22
Departure of Directors or Certain Officers
5:00pm
8-K
EX-10.1
1ie2ppt vdn9jmtockl
16 Nov 22
Entry into a Material Definitive Agreement
5:08pm
8-K
EX-10.1
qhlp5q9dx3r rn7liwr
21 Oct 22
Entry into a Material Definitive Agreement
4:00pm
8-K
EX-10.1
rak0ki3t6wpgm
14 Oct 22
Entry into a Material Definitive Agreement
4:29pm
8-K
EX-10.1
owemq1tu
30 Aug 22
Jaguar Health Secures Additional Capital Through Sale of Royalty Rights Related to Future Crofelemer and Lechlemer Revenue Stream
4:30pm
8-K/A
EX-10.1
xxj1 ebg67e6
24 Aug 22
Financial Statements and Exhibits
5:00pm
8-K
EX-10.2
ibarkfm7m44y l9j5a
23 Aug 22
Entry into a Material Definitive Agreement
4:30pm